Glucagon-Like Peptide-1 Receptor Agonists: Beta-Cell Protection or Exhaustion?

Daniël H van Raalte; C Bruce Verchere

doi:10.1016/j.tem.2016.04.009

Glucagon-Like Peptide-1 Receptor Agonists: Beta-Cell Protection or Exhaustion?

Daniël H van Raalte, C Bruce Verchere

Internal medicine

Research output: Contribution to journal › Short survey › Academic › peer-review

Abstract

Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.

Original language	English
Pages (from-to)	442-5
Number of pages	4
Journal	TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume	27
Issue number	7
DOIs	https://doi.org/10.1016/j.tem.2016.04.009
Publication status	Published - Jul 2016

Access to Document

10.1016/j.tem.2016.04.009

Cite this

@article{9d2a5ffc82e54f43add629608bcb5fe4,

title = "Glucagon-Like Peptide-1 Receptor Agonists: Beta-Cell Protection or Exhaustion?",

abstract = "Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.",

keywords = "Journal Article",

author = "{van Raalte}, {Dani{\"e}l H} and Verchere, {C Bruce}",

year = "2016",

month = jul,

doi = "10.1016/j.tem.2016.04.009",

language = "English",

volume = "27",

pages = "442--5",

journal = "TRENDS IN ENDOCRINOLOGY AND METABOLISM",

issn = "1043-2760",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Glucagon-Like Peptide-1 Receptor Agonists

T2 - Beta-Cell Protection or Exhaustion?

AU - van Raalte, Daniël H

AU - Verchere, C Bruce

PY - 2016/7

Y1 - 2016/7

N2 - Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.

AB - Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.

KW - Journal Article

U2 - 10.1016/j.tem.2016.04.009

DO - 10.1016/j.tem.2016.04.009

M3 - Short survey

C2 - 27160799

VL - 27

SP - 442

EP - 445

JO - TRENDS IN ENDOCRINOLOGY AND METABOLISM

JF - TRENDS IN ENDOCRINOLOGY AND METABOLISM

SN - 1043-2760

IS - 7

ER -